National and Kapodistrian University of Athens
uoa.grLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
162
Active
47
Phase 3
8
Total enrollment
32,525
Pipeline matrix
Showing 21 of 21 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| dexpanthenol and hyaluronic acid preservative-free eye artificial tears eye drops | — | — | — | — | — | 1 | |
| Beta blocker | — | — | — | — | — | 1 | |
| Anifrolumab | — | — | — | — | — | 1 | |
| Dextrose 15% and lidocaine 1% infiltration | — | — | — | — | — | 1 | |
| Lidocaine 1% infiltration | — | — | — | — | — | 1 | |
| Lidocaine and Ketamine | — | — | — | — | — | 1 | |
| Active Placebo (Midazolam) | — | — | — | — | — | 1 | |
| Semaglutide or Tirzepatide | — | — | — | — | — | 1 | |
| Mepolizumab 100 MG | — | — | — | — | — | 1 | |
| ERAS group | — | — | — | — | — | 1 | |
| Control group | — | — | — | — | — | 1 | |
| Dextrose 5% and Lidocaine | — | — | — | — | — | 1 | |
| Lidocaine | — | — | — | — | — | 1 | |
| antibiotic prophylaxis | — | — | — | — | — | 1 | |
| Sodium Hypochlorite. | — | — | — | — | — | 1 | |
| Hydrogen peroxide. | — | — | — | — | — | 1 | |
| Sodium Sulfate. | — | — | — | — | — | 1 | |
| Sevoflurane | — | — | — | — | — | 1 | |
| Desflurane | — | — | — | — | — | 1 | |
| Subacromial Bursa Tissue Reimplantation | — | — | — | — | — | 1 | |
| Platelet-Rich Plasma (PRP) Injections | — | — | — | — | — | 1 |
Next readouts
- 2024-12-12
- 2025-11
- 2026-01-30
- 2026-03-31
- 2026-08-31
- 2026-12
- 2026-12
- 2027-01
- 2027-01-30
- 2027-07-15
Top conditions
- Infertility5
- Dental Plaque4
- Aortic Valve Stenosis4
- Knee Osteoarthritis3
- Breast Cancer3
- Hip Fractures3
- Atrial Fibrillation3
- Gynecologic Cancer3
Frequently asked questions about National and Kapodistrian University of Athens
- How many clinical trials does National and Kapodistrian University of Athens have on ClinicalTrials.gov?
- National and Kapodistrian University of Athens is listed as the lead sponsor on 162 clinical trials in ClinicalTrials.gov, 47 of which are currently active (recruiting, enrolling, or ongoing).
- How many of National and Kapodistrian University of Athens's trials are in Phase 3?
- 8 of National and Kapodistrian University of Athens's trials are in Phase 3, spread across 21 active drug programs.
- What therapeutic areas does National and Kapodistrian University of Athens focus on?
- National and Kapodistrian University of Athens's most-studied conditions on ClinicalTrials.gov are Infertility, Dental Plaque, Aortic Valve Stenosis, Knee Osteoarthritis, Breast Cancer.
- When are National and Kapodistrian University of Athens's next clinical trial readouts?
- National and Kapodistrian University of Athens has 10 upcoming primary-completion readouts tracked here; the soonest is “Clinical Investigation of Chemomechanical Parameters for an Efficient Disinfection of the Root Canal”, expected around 2024-12-12.